Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple-Center, Observer-Blinded, Randomized, Placebo-Controlled, Single & Multiple Ascending Dose Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, & Food Effect of RO5024048 in Healthy Volunteers & in Patients With Chronic HCV Infection

NCT00382798 is registered in ClinicalTrials.gov with Pharmasset as lead sponsor.

NCT NCT00382798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00382798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple-Center, Observer-Blinded, Randomized, Placebo-Controlled, Single & Multiple Ascending Dose Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, & Food Effect of RO5024048 in Healthy Volunteers & in Patients With Chronic HCV Infection
Lead sponsor
Pharmasset
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2006
Completion date
September 30, 2008
Enrollment
75 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, hepatitis c virus